These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 996285)

  • 1. Discriminable stimuli produced by hallucinogens.
    Kuhn DM; White FJ; Appel JB
    Psychopharmacol Commun; 1976; 2(4):345-8. PubMed ID: 996285
    [No Abstract]   [Full Text] [Related]  

  • 2. Psilocybin-induced stimulus control in the rat.
    Winter JC; Rice KC; Amorosi DJ; Rabin RA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some observations on the behavioural effects of hallucinogenic drugs on rats: potentiation by two drugs affecting monoamine metabolism.
    Tonge SR; Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):168-76. PubMed ID: 5010826
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for the action of d-lysergic acid diethylamide, mescaline and bufotenine on 5-hydroxytryptamine receptors in umbilical vasculature.
    Dyer DC
    J Pharmacol Exp Ther; 1974 Feb; 188(2):336-41. PubMed ID: 4359552
    [No Abstract]   [Full Text] [Related]  

  • 5. The hallucinogens and the inhalants.
    Cohen S
    Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
    Cameron OG; Appel JB
    Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological action spectra of hallucinogens].
    Waser PG
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of hallucinogens on electroencephalograms].
    Oughourlian JM; Rougeul A; Verdeaux J
    Therapie; 1971; 26(5):953-68. PubMed ID: 5160349
    [No Abstract]   [Full Text] [Related]  

  • 9. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
    Koerner J; Appel JB
    Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of isolation-induced attack behavior of mice by drugs.
    Uyeno ET
    J Pharm Sci; 1966 Feb; 55(2):215-6. PubMed ID: 5923276
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological studies on para-bromo-methamphetamine (V-111) and LSD.
    Knoll J; Vizi ES; Knoll B
    Acta Physiol Acad Sci Hung; 1970; 37(1):151-70. PubMed ID: 5433553
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrographic and behavioral effects of various hallucinogens in the free cat].
    Rougeul A; Verdeaux J; Letalle A
    Rev Neurol (Paris); 1969 Jun; 120(6):391-4. PubMed ID: 5379317
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of hallucinogenic drugs upon in vivo brain levels of adenine nucleotides, phosphocreatine and inorganic phosphate in the rat.
    Lewis JJ; Ritchie AP; van Petten GR
    Br J Pharmacol Chemother; 1965 Dec; 25(3):631-7. PubMed ID: 5296835
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative effects of hallucinogenic drugs on behavior of the cat.
    Jacobs BL; Trulson ME; Stark AD; Christoph GR
    Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neuropharmacologic similarities and differences between the hallucinogens and the antidepressants].
    Thuillier J; Nakajima H
    Arzneimittelforschung; 1966 Feb; 16(2):222-6. PubMed ID: 6014084
    [No Abstract]   [Full Text] [Related]  

  • 16. Hallucinogens and dominance behavior of the rat.
    Uyeno ET
    Proc West Pharmacol Soc; 1967; 10():94. PubMed ID: 6055511
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychedelic drugs and creativity.
    Krippner S
    J Psychoactive Drugs; 1985; 17(4):235-45. PubMed ID: 4087078
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 19. Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus.
    McCall RB; Aghajanian GK
    Life Sci; 1980 Apr; 26(14):1149-56. PubMed ID: 7392793
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.